The Ensign Group Acquires 3 Skilled Nursing Facilities in Colorado

April 6, 2021

The Ensign Group, Inc., the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational, and speech therapies, and other rehabilitative and healthcare services, announced today that it acquired the operations of the following skilled nursing facilities in Colorado:

These acquisitions were effective April 1, 2021, and will be subject to a long-term, triple net lease.

“We are pleased to be adding these operations to our Colorado portfolio and look forward to the contribution they will make to our same-store operations in the state,” said Barry Port, Ensign’s Chief Executive Officer.

Dave Jorgensen, President of Endura Healthcare, Inc., Ensign’s Colorado-based subsidiary, added, “Each of these operations is well situated to become the operation-of-choice in their markets. We are excited to work together with our healthcare partners as we strive to provide top-notch care for our patients and their families.”

This acquisition brings Ensign’s growing portfolio to 235 healthcare operations, 22 of which also include assisted living operations, across thirteen states. Ensign owns 94 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, assisted living, and other healthcare-related businesses throughout the United States.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”